Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Is AMH useful to reduce low ovarian response to GnRH antagonist protocol in oocyte donors?

Martínez F, Clua E, Carreras O, Tur R, Rodríguez I, Barri PN.

Gynecol Endocrinol. 2013 Aug;29(8):754-7. doi: 10.3109/09513590.2013.801443. Epub 2013 Jun 12.

PMID:
23758138
2.

Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors.

Polyzos NP, Stoop D, Blockeel C, Adriaensen P, Platteau P, Anckaert E, Smitz J, Devroey P.

Reprod Biomed Online. 2012 May;24(5):532-9. doi: 10.1016/j.rbmo.2012.01.024. Epub 2012 Feb 3.

PMID:
22417669
3.

Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.

Tsakos E, Tolikas A, Daniilidis A, Asimakopoulos B.

Arch Gynecol Obstet. 2014 Dec;290(6):1249-53. doi: 10.1007/s00404-014-3332-3. Epub 2014 Jul 8.

PMID:
25001569
4.

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.

Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R.

Fertil Steril. 2013 May;99(6):1644-53. doi: 10.1016/j.fertnstert.2012.12.048. Epub 2013 Feb 5.

5.

Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection.

Polyzos NP, Tournaye H, Guzman L, Camus M, Nelson SM.

Fertil Steril. 2013 Aug;100(2):430-7. doi: 10.1016/j.fertnstert.2013.04.029. Epub 2013 May 10.

PMID:
23668992
6.

Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.

Hamdine O, Eijkemans MJ, Lentjes EW, Torrance HL, Macklon NS, Fauser BC, Broekmans FJ.

Hum Reprod. 2015 Jan;30(1):170-8. doi: 10.1093/humrep/deu266. Epub 2014 Oct 29.

PMID:
25355590
7.

Is assessment of anti-Müllerian hormone and/or antral follicle count useful in the prediction of ovarian response in expected normal responders treated with a fixed dose of recombinant FSH and GnRH antagonists? A prospective observational study.

Ganidou MA, Kolibianakis EM, Venetis CA, Gerou S, Makedos GA, Klearchou N, Tarlatzis BC.

Gynecol Endocrinol. 2014 Nov;30(11):817-21. doi: 10.3109/09513590.2014.938624. Epub 2014 Jul 3.

PMID:
24989633
8.
9.

Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.

Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.

Fertil Steril. 2009 Nov;92(5):1586-93. doi: 10.1016/j.fertnstert.2008.08.127. Epub 2008 Oct 18.

PMID:
18930213
10.

Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.

Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY.

Fertil Steril. 2008 Apr;89(4):860-7. doi: 10.1016/j.fertnstert.2007.04.010. Epub 2008 Feb 4.

PMID:
18249372
11.
12.
13.

Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.

El-Mazny A, Abou-Salem N.

Gynecol Endocrinol. 2013 Sep;29(9):826-9. doi: 10.3109/09513590.2013.813466. Epub 2013 Jul 15.

PMID:
23855354
14.

What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?

Knez J, Kovačič B, Medved M, Vlaisavljević V.

Reprod Biol Endocrinol. 2015 Jun 10;13:58. doi: 10.1186/s12958-015-0049-5.

15.

Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pre-treatment.

Andersen AN, Witjes H, Gordon K, Mannaerts B; Xpect investigators.

Hum Reprod. 2011 Dec;26(12):3413-23. doi: 10.1093/humrep/der318. Epub 2011 Sep 27.

PMID:
21954280
16.

Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.

Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O, Oktem M.

J Assist Reprod Genet. 2013 Jun;30(5):657-65. doi: 10.1007/s10815-013-9975-3. Epub 2013 Mar 19.

17.

Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?

Burks HR, Ross L, Opper N, Paulson E, Stanczyk FZ, Chung K.

Fertil Steril. 2015 Sep;104(3):643-8. doi: 10.1016/j.fertnstert.2015.06.018. Epub 2015 Jul 6.

PMID:
26158904
18.

[Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].

He Y, Xia R, Chen X, Ye D, Tang Y, Li P, Niu J, Chen S.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Feb;33(2):216-20. Chinese.

19.

Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.

Tolikas A, Tsakos E, Gerou S, Prapas Y, Loufopoulos A.

Hum Fertil (Camb). 2011 Dec;14(4):246-53. doi: 10.3109/14647273.2011.608464.

PMID:
22088130
20.

The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.

Majumder K, Gelbaya TA, Laing I, Nardo LG.

Eur J Obstet Gynecol Reprod Biol. 2010 Jun;150(2):166-70. doi: 10.1016/j.ejogrb.2010.02.029. Epub 2010 Mar 11.

PMID:
20223579

Supplemental Content

Support Center